Arcadia Biosciences, Inc. - COM (RKDA)

Q2 2025 13F Holders as of 6/30/2025

Type / Class
Equity / COM
Number of holders
14
Total 13F shares, excl. options
59.2K
Shares change
-17.3K
Total reported value, excl. options
$259K
Value change
-$74.4K
Number of buys
4
Number of sells
-3
Price
$4.31

Significant Holders of Arcadia Biosciences, Inc. - COM (RKDA) as of Q2 2025

15 filings reported holding RKDA - Arcadia Biosciences, Inc. - COM as of Q2 2025.
Arcadia Biosciences, Inc. - COM (RKDA) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 59.2K shares .
Largest 10 shareholders include Mariner, LLC (14.5K shares), VANGUARD GROUP INC (14K shares), GEODE CAPITAL MANAGEMENT, LLC (12.8K shares), STATE STREET CORP (12.1K shares), UBS Group AG (2.54K shares), Tower Research Capital LLC (TRC) (1.92K shares), MORGAN STANLEY (787 shares), ATTICUS WEALTH MANAGEMENT, LLC (272 shares), SBI Securities Co., Ltd. (120 shares), and OSAIC HOLDINGS, INC. (75 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.